window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : November 16, 2025

  • News
  • About Us
Contact Us

cancer diagnostics

  • Oncology,Patient Centricity,Regulatory Affairs

    UK clears Mainz Biomed’s ColoAlert for colorectal cancer screening

    Mainz Biomed has received official registration from the UK Medicines [...]

    September 8, 2025
  • Clinical Trials,Drug Development,Market Access & Commercialization,Oncology,Partnerships & Funding,Precision medicine,Regulatory Affairs,Research & Development,Technology and platforms

    Mainz Biomed targets US approval for next-gen CRC test and expands into pancreatic cancer

    Mainz Biomed says it is preparing to launch a pivotal [...]

    July 18, 2025
  • Artificial Intelligence,Clinical Development,Oncology,Partnerships & Funding,Precision medicine

    One Biosciences raises €15M to advance AI-driven single-cell oncology platform

    One Biosciences, a precision oncology techbio company specialising in clinical-grade [...]

    July 17, 2025
  • Oncology

    Tagomics secures £860k Innovate UK grant to advance early detection of colorectal cancer

    Project aims to apply multiomic profiling for non-invasive diagnostic development [...]

    June 10, 2025
  • Artificial Intelligence,Drug Development,Partnerships & Funding,Precision medicine,Technology and platforms

    Biostate AI raises $12M to build the ‘Netflix’ of molecular diagnostics using RNAseq and GenAI

    Biostate AI has raised $12 million in Series A funding [...]

    May 23, 2025
  • Patient Centricity,Technology and platforms,Uncategorised

    SpotitEarly targets US market with AI-canine breath test for early cancer detection

    A biotech company combining artificial intelligence with canine scent detection [...]

    May 22, 2025
  • Clinical Trials

    ctDNA shown to strongly correlate with treatment outcomes across tumor types, study finds

    April 24, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction
    Categories: Artificial Intelligence, Biotech, Clinical Development, Diagnostics, Digital Health, Drug Development, Global health, Healthcare leadership, Precision medicine, Women's Health
  • FDA approves Kura and Kyowa Kirin’s ziftomenib for relapsed or refractory AML
    Categories: Drug approval, Oncology, Pharmaceuticals and therapeutics
  • Successful treatment for ALS could deliver billions in global value
    Categories: Neurosciences, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top